This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

2024 ASCO® Annual Meeting Insights Hub
J

ASCO® 2024 Insights: "KEYNOTE-942 Trial - 3-Year Update on mRNA-4157 & Pembro in Resected Melanoma"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Jeffrey Weber
By 2024 ASCO® Annual Meeting Insights Hub FEATURING Jeffrey Weber
207 views
June 12, 2024

Chapters

KEYNOTE-942 Trial & mRNA-4157 Overview

00:00

Trial Design & Patient Eligibility

02:49

3-Year Treatment Results & Survival Data

04:22

Safety Profile & Biomarker Analyses

06:56

0 Comments
Login to view comments. Click here to Login

2024 ASCO® Annual Meeting Insights Hub: Skin Videos

05:27
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Biomarker Analysis & Updated Clinical…

Feat. L. Burton
35:23
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "My Personal Highlights in Melanoma"

Feat. S. Patel
24:27
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Highlights in Melanoma - Neoadjuvant and A…

Feat. Z. Eroglu
View All

Related Content

AUTOPLAY
20:09
Scripps Health

Dysplastic Nevi: Navigating the Risk Landscape

Feat. B. Kelley
12:46
Stanford Medicine

FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: …

Feat. A. Betof Warner
35:23
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "My Personal Highlights in Melanoma"

Feat. S. Patel
09:00
AAD 2024

AAD 2024 Insights: What's New In Nail Tumors

Feat. J. Dominguez-Cherit
11:05
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Highlights in Early Stage, 1L Metastatic, …

Feat. D. Johnson
25:29
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Insights in Melanoma"

Feat. O. Hamid
22:58
Tarek Haykal

The Role of Adjuvant IO vs. Targeted Therapy for BRAF V600-Mutant St…

18:28
Vanderbilt University Medical Center (VUMC)

NCCN Guidelines Updates for the Management of Cutaneous Melanoma: Ne…

Feat. D. Johnson
09:26
Oncology Data Advisor

The NADINA Trial - A Paradigm Shift in Melanoma Treatment

Feat. M. Hadfield
24:27
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Highlights in Melanoma - Neoadjuvant and A…

Feat. Z. Eroglu
08:41
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "NADINA Trial - Neoadjuvant Nivo + Ipi in …

Feat. C. Blank
23:09
Total Health

Key Updates in Skin Melanoma

Feat. R. Seedor
24:29
Scripps Health

2024 Update on Melanoma, the Primary Lesion: Biopsy, Excision, and M…

Feat. D. Kent
09:50
Ricky Frazer

Overview of Adjuvant and Metastatic Landscape and Immunotherapy Toxc…

25:44
Scripps Health

Melanoma in the Molecular Age - Part 1: New Tools for Diagnosis, Pro…

Feat. G. Hosler
21:04
Penn Medicine Abramson Cancer Center

Pediatric Melanoma

Feat. M. Jen
17:39
Melanoma Bridge 2023

Major Emerging Paradigm Shifts That Will Change Melanoma Management …

Feat. A. Eggermont
08:48
David Polsky

Promoting Skin Self-Exam for the Secondary Prevention of Melanoma

52:19
Winship Melanoma and Cutaneous Oncology Symposium

2024 Updates on Neoadjuvant Therapy for Resectable Melanoma

Feat. S. Patel
15:18
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Adopting Cutting-Edge Cell Therapies in Me…

Feat. A. Betof Warner